Chronic Thromboembolic Pulmonary Hypertension: the Bedside

Area of Science:

• Cardiology
• Pulmonology
• Vascular Medicine

Background:

• Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious complication of acute pulmonary embolism (PE).
• It involves organized scar-like obstruction in pulmonary vasculature, potentially leading to right ventricular (RV) failure.
• CTEPH is classified under group 4 Pulmonary Hypertension (PH).

Purpose of the Study:

• To provide an overview of the current diagnostic approaches for CTEPH.
• To summarize the contemporary management strategies for CTEPH.
• To highlight the complexities and limitations in treating CTEPH.

Main Methods:

• Review of current literature on CTEPH diagnosis and management.
• Discussion of multimodality diagnostic approaches.
• Analysis of treatment options including surgery, percutaneous interventions, and medical therapies.

Main Results:

• CTEPH diagnosis requires a sophisticated, multimodality approach to distinguish it from other conditions.
• Management strategies are diverse, encompassing surgical pulmonary endarterectomy, percutaneous balloon angioplasty, and medical treatments.
• Current medical therapies for CTEPH are often repurposed from pulmonary arterial hypertension (PAH) treatments.
• While treatments can alleviate symptoms, they may not fully reverse the underlying pathology of CTEPH.

Conclusions:

• Effective CTEPH management is complex and requires a tailored, multidisciplinary approach.
• Accurate diagnosis is crucial for appropriate treatment selection.
• Further research is needed to develop therapies that can reverse the underlying pathology of CTEPH.